Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis.
Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis.
Polymyositis associated with interstitial pulmonary fibrosis and glomerulonephritis. A report of two autopsy cases.
Management of interstitial lung disease associated with connective tissue disease.
Mathai SC, Danoff SK.
BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819.
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay.
Palmucci S, Galioto F, Fazio G, Ferlito A, Cancemi G, Di Mari A, Sambataro G, Sambataro D, Zanframundo G, Mauro LA, Foti PV, Vancheri C, Basile A.
Insights Imaging. 2022 Jun 29;13(1):108. doi: 10.1186/s13244-022-01243-2.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Yoo H, Hino T, Hwang J, Franks TJ, Han J, Im Y, Lee HY, Chung MP, Hatabu H, Lee KS.
Eur J Radiol Open. 2022 Apr 7;9:100419. doi: 10.1016/j.ejro.2022.100419. eCollection 2022.
Anti-Jo-1 antibodies.
Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A.
Autoimmunity. 2005 Feb;38(1):73-8. doi: 10.1080/08916930400022640.
Idiopathic pulmonary fibrosis.
Meltzer EB, Noble PW.
Orphanet J Rare Dis. 2008 Mar 26;3:8. doi: 10.1186/1750-1172-3-8.
Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.
Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ.
Q J Med. 1990 Oct;77(282):1019-38. doi: 10.1093/qjmed/77.1.1019.
Comparison of Chest High-Resolution Computed Tomography Findings in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive and Antibody-Negative Progressive Pulmonary Fibrosis with Polymyositis/Dermatomyositis.
Sato N, Kotani T, Koyama M, Matsuda S, Sakamoto A, Shou Y, Oe K, Takeuchi T, Osuga K.
J Clin Med. 2025 Feb 27;14(5):1601. doi: 10.3390/jcm14051601.
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
Zanatta E, Cocconcelli E, Castelli G, Giraudo C, Fraia AS, De Zorzi E, Gatto M, Ienna L, Treppo E, Malandrino D, Cereser L, Emmi G, Giannelli F, Bellani S, Martini A, Moccaldi B, Ghirardello A, Avouac J, Quartuccio L, Allanore Y, Doria A, Spagnolo P, Balestro E, Iaccarino L.
RMD Open. 2023 Aug;9(3):e003121. doi: 10.1136/rmdopen-2023-003121.
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C).
David P, Sinha S, Iqbal K, De Marco G, Taheri S, McLaren E, Maisuria S, Arumugakani G, Ash Z, Buckley C, Coles L, Hettiarachchi C, Payne E, Savic S, Smithson G, Slade M, Shah R, Marzo-Ortega H, Keen M, Lawson C, Mclorinan J, Nizam S, Reddy H, Sharif O, Sultan S, Tran G, Wood M, Wood S, Ghosh P, McGonagle D.
EBioMedicine. 2024 Jun;104:105136. doi: 10.1016/j.ebiom.2024.105136. Epub 2024 May 8.
Immunosuppressive drug therapy.
McCune WJ, Vallance DK, Lynch JP 3rd.
Curr Opin Rheumatol. 1994 May;6(3):262-72. doi: 10.1097/00002281-199405000-00004.
